Edmond de Rothschild Holding’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28,785
Closed -$3.47M 768
2023
Q1
$3.47M Hold
28,785
0.08% 199
2022
Q4
$3.3M Buy
28,785
+1,485
+5% +$164K 0.08% 194
2022
Q3
$2.8M Hold
27,300
0.07% 206
2022
Q2
$2.77M Buy
+27,300
New +$2.98M 0.07% 223
2022
Q1
Sell
-3,400
Closed -$389K 858
2021
Q4
$389K Buy
+3,400
New +$388K 0.01% 447

Other funds holding BSX.PRA

Edmond de Rothschild Holding's BSX.PRA Position: Q2 2023 in Review

Edmond de Rothschild Holding sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 28,785 shares — an estimated $3.47M sold.

Edmond de Rothschild Holding first reported a position in BSX.PRA in Q4 2021 and held it in 5 quarters. The position peaked at $3.47M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Edmond de Rothschild Holding reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 28,785 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $3.47M.
  • Edmond de Rothschild Holding first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 5 quarters.
  • Edmond de Rothschild Holding's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $3.47M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2023, filed 9 Aug 2023.